Skip to main content

Compass Therapeutics, Inc 8-K, filed Jun 23, 2020

Compass Therapeutics, Inc. (CMPX)

8-K 2020-06-23 For: 2020-06-17
View Original
Added on April 10, 2026

About this 8-K

Compass Therapeutics, Inc filed this 8-K on June 23, 2020, reporting on events of June 17, 2020.

Items reported

  • Item 1.01: Entered into a material agreement
  • Item 2.01: Completed an acquisition or sale of assets
  • Item 3.02: Unregistered sale of equity
  • Item 4.01: Change of auditor
  • Item 5.01: Change in control
  • Item 5.02: Director or officer change, or executive pay
  • Item 5.03: Charter or bylaw amendment, or fiscal year change
  • Item 5.06: Change in shell company status
  • Item 9.01: Financial statements and exhibits